Interleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: Anakinra Randomized Trial (MAGiC-ART)
Abstract Background Sarcoidosis is an inflammatory disease characterized by the formation of granulomas, which involve the heart in up to 25% of patients. Cardiac sarcoidosis can lead to life threatening arrhythmias and heart failure. While corticosteroids have been used as a treatment for over 50 y...
Guardado en:
Autores principales: | Jordana Kron, Thomas Crawford, Virginia Mihalick, Frank Bogun, Jennifer H. Jordan, Todd Koelling, Huzaefah Syed, Aamer Syed, Thomas Iden, Kelly Polly, Emily Federmann, Kirsta Bray, Sangeeta Lathkar-Pradhan, Shilpa Jasti, Lynda Rosenfeld, David Birnie, Melissa Smallfield, Le Kang, Alpha Berry Fowler, Amy Ladd, Kenneth Ellenbogen, Benjamin Van Tassell, W. Gregory Hundley, Antonio Abbate |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4c8d9acdec424382b63edf754d992e7d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Management of Cardiac Sarcoidosis in 2020
por: Nisha Gilotra, et al.
Publicado: (2020) -
Comment on ‘Management of Cardiac Sarcoidosis in 2020’
por: Socrates Korovesis, et al.
Publicado: (2021) -
Cardiac sarcoidosis: from diagnosis to treatment
por: Kristyna Kysperska, et al.
Publicado: (2021) -
Cardiac Sarcoidosis: When and How to Treat Inflammation
por: Gerard T Giblin, et al.
Publicado: (2021) -
Diagnosis and Therapy of Cardiac Sarcoidosis: A Clinical Perspective
por: Steven R Sigman
Publicado: (2019)